Home » News & Updates
PRN® Pharmacal has updated the product labels on their line of veterinary nutritional supplements. The new labels are designed to make information more clear and concise for both the veterinarian and the pet owner. Products with updated labels include: STAT® High...
Pegasus Laboratories dba PRN Pharmacal will begin transitioning KBroVet®-CA1 (potassium bromide chewable tablets) to a new French vanilla flavor in Fall 2022. This change to an all-natural, plant-based flavorant comes in response to concerns around increased allergies...
Pegasus Laboratories dba PRN Pharmacal made a major investment in its future by acquiring the property neighboring their Pensacola facility. This new property, which includes a 169,000 square foot building situated on 10 acres, will nearly triple its manufacturing...
In an effort to offer industry professionals more continuing education course options, PRN® Pharmacal partnered with Clinician’s Brief to leverage their existing comprehensive training platform. Effective January 1, 2022, all UniversityPRN.com courses were transferred...
The US Food and Drug Administration has granted KBroVet®-CA1 (potassium bromide chewable tablets) conditional approval for veterinary use in the management of seizures in dogs with idiopathic epilepsy. PRN® Pharmacal developed KBroVet-CA1 to provide a consistent and...